Growth Metrics

Insight Molecular Diagnostics (IMDX) Non-Current Deferred Tax Liability (2020 - 2023)

Insight Molecular Diagnostics' Non-Current Deferred Tax Liability history spans 2 years, with the latest figure at $2.2 million for Q3 2023.